Can big data from a bad flu season yield insights into all-cause mortality and help guide insurance risk assessment? RGA and Blue Dot partner to explore the global spread of infectious disease and arrive at fascinating insights.
Chikungunya fever (CHK) is a febrile illness associated with severe arthralgia and rash. CHK was first identified in Tanzania in the early 1952 and has caused periodic outbreaks in Asia and Africa since the 1960s. The virus is transmitted from human to human by vectors, infected Aedes aegypti and/ or Aedes albopictus female mosquitoes.
In February 2015 the Ministry of Health in Brazil investigated and later confirmed an outbreak of Zika virus that has since then spread rapidly through Latin America.1,2 Infection with Zika commonly causes very mild symptoms but this outbreak has created global news headlines and prompted some startling reactions. The WHO declared a global public health emergency, Brazil deployed 200,000 troops to battle mosquitos and women across Latin America were advised to postpone pregnancy.
This webcast will cover what we currently know about emerging global infectious diseases, reflecting on events from the 1918 Spanish flu to the current Ebola epidemic in West Africa. We will also discuss what tools are available to help the insurance industry better plan for and respond to tomorrow’s inevitable epidemics.
The range of infectious diseases that cause distress, illness and death remains truly staggering. Malaria, pneumonia, HIV, meningitis, plague, yellow fever, cholera, influenza and most recently Ebola continue to influence not only individuals but the economic and social life within large regions of the world. Most countries have experienced epidemics of one form or another over the past decade. The majority has been contained, but the H1N1 influenza outbreak of 2009 briefly demonstrated the potential for global reach.